Daiichi Sankyo s cholesterol-lowering drugs recommended for NHS use pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
29th April 2021
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Daiichi Sankyo’s cholesterol drugs Nilemdo and Nustendi for use on the NHS, benefitting around 70,000 adults in England with high cholesterol.
NICE has recommended the use of Nilemdo (bempedoic acid) with ezetimibe or in the fixed-dose combination form – Nustendi.
Patients with primary hypercholesterolaemia or mixed dyslipidemia – high cholesterol – will be offered treatment with bempedoic acid with ezetimibe when statins cannot be taken or have not worked.
The current treatment for these patients includes dietary changes aimed at lowering low-density lipoprotein cholesterol (LDL-C) levels.